Klaus-Dieter Stoll

563 total citations
14 papers, 361 citations indexed

About

Klaus-Dieter Stoll is a scholar working on Experimental and Cognitive Psychology, Psychiatry and Mental health and Pharmacology. According to data from OpenAlex, Klaus-Dieter Stoll has authored 14 papers receiving a total of 361 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Experimental and Cognitive Psychology, 5 papers in Psychiatry and Mental health and 4 papers in Pharmacology. Recurrent topics in Klaus-Dieter Stoll's work include Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes (4 papers), Treatment of Major Depression (4 papers) and Psychosomatic Disorders and Their Treatments (2 papers). Klaus-Dieter Stoll is often cited by papers focused on Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes (4 papers), Treatment of Major Depression (4 papers) and Psychosomatic Disorders and Their Treatments (2 papers). Klaus-Dieter Stoll collaborates with scholars based in Germany, Switzerland and Belgium. Klaus-Dieter Stoll's co-authors include Hans‐Peter Volz, I. W. Reimann, Hans‐Jürgen Möller, Bernhard J. Steinhoff, Barbara Tettenborn, Hans‐Jürgen Möller, G. P. Menge, Walter J. Paulus, Stefan Stodieck and B. Müller‐Oerlinghausen and has published in prestigious journals such as Epilepsia, Epilepsy Research and Journal of Clinical Psychopharmacology.

In The Last Decade

Klaus-Dieter Stoll

14 papers receiving 343 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Klaus-Dieter Stoll Germany 9 189 95 84 76 73 14 361
Hilde Lunde Norway 10 177 0.9× 74 0.8× 47 0.6× 42 0.6× 116 1.6× 16 486
Michael J. Napoliello United States 7 192 1.0× 91 1.0× 46 0.5× 96 1.3× 142 1.9× 11 359
M Viukari Finland 12 259 1.4× 103 1.1× 29 0.3× 58 0.8× 75 1.0× 36 442
E. Lenzinger Austria 12 173 0.9× 34 0.4× 116 1.4× 36 0.5× 105 1.4× 27 525
S Malcolm United States 10 351 1.9× 44 0.5× 80 1.0× 35 0.5× 19 0.3× 19 604
Josef Schöpf Switzerland 10 172 0.9× 24 0.3× 39 0.5× 62 0.8× 89 1.2× 27 400
Felix Veloso Canada 7 288 1.5× 118 1.2× 20 0.2× 45 0.6× 63 0.9× 7 409
Christian Geretsegger Austria 11 259 1.4× 27 0.3× 46 0.5× 38 0.5× 74 1.0× 16 428
M. Zivkov United States 10 367 1.9× 47 0.5× 38 0.5× 60 0.8× 71 1.0× 14 582
Neil M. Kurtz United States 11 189 1.0× 21 0.2× 39 0.5× 38 0.5× 71 1.0× 18 393

Countries citing papers authored by Klaus-Dieter Stoll

Since Specialization
Citations

This map shows the geographic impact of Klaus-Dieter Stoll's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Klaus-Dieter Stoll with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Klaus-Dieter Stoll more than expected).

Fields of papers citing papers by Klaus-Dieter Stoll

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Klaus-Dieter Stoll. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Klaus-Dieter Stoll. The network helps show where Klaus-Dieter Stoll may publish in the future.

Co-authorship network of co-authors of Klaus-Dieter Stoll

This figure shows the co-authorship network connecting the top 25 collaborators of Klaus-Dieter Stoll. A scholar is included among the top collaborators of Klaus-Dieter Stoll based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Klaus-Dieter Stoll. Klaus-Dieter Stoll is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
2.
Volz, Hans‐Peter & Klaus-Dieter Stoll. (2004). Clinical Trials with Sigma Ligands. Pharmacopsychiatry. 37(S 3). 214–220. 53 indexed citations
3.
Möller, Hans‐Jürgen, Hans‐Peter Volz, & Klaus-Dieter Stoll. (2003). Psychopharmacotherapy of somatoform disorders: effects of opipramol on symptoms of somatization, anxiety, and depression. Acta Neuropsychiatrica. 15(4). 217–226. 4 indexed citations
4.
Gerlach, Klaus, Thomas Uhlig, André Klassen, et al.. (2002). Effects of Opipramol as an Evening Anaesthesiologic Premedication. Neuropsychobiology. 46(3). 161–166. 8 indexed citations
5.
Möller, Hans‐Jürgen, Hans‐Peter Volz, I. W. Reimann, & Klaus-Dieter Stoll. (2001). Opipramol for the Treatment of Generalized Anxiety Disorder: A Placebo-Controlled Trial Including an Alprazolam-Treated Group. Journal of Clinical Psychopharmacology. 21(1). 59–65. 79 indexed citations
6.
Volz, Hans‐Peter, Hans‐Jürgen Möller, I. W. Reimann, & Klaus-Dieter Stoll. (2000). Opipramol for the treatment of somatoform disorders results from a placebo-controlled trial. European Neuropsychopharmacology. 10(3). 211–217. 37 indexed citations
7.
Angst, Jules, Attila Borbély, Rolf R. Engel, et al.. (1995). Report on the Sixth Consensus Conference on the Methodology of Clinical Trials with Hypnotic Drugs. Pharmacopsychiatry. 28(1). 2–7. 10 indexed citations
8.
Angst, Jules, Per Bech, J. Bruinvels, et al.. (1994). Report on the Fifth Consensus Conference: Methodology of Long-Term Clinical Trials in Psychiatry. Pharmacopsychiatry. 27(3). 101–107. 7 indexed citations
9.
Steinhoff, Bernhard J., Klaus-Dieter Stoll, Stefan Stodieck, & Walter J. Paulus. (1992). Hyponatremic coma under oxcarbazepine therapy. Epilepsy Research. 11(1). 67–70. 42 indexed citations
10.
Tettenborn, Barbara, et al.. (1992). Oxcarbazepine Does Not Affect the Anticoagulant Activity of Warfarin. Epilepsia. 33(6). 1145–1148. 55 indexed citations
11.
Angst, Jules, Per Bech, Pascal Boyer, et al.. (1989). Consensus Conference on the Methodology of Clinical Trials of Antidepressants, Zurich, march 1988: Report of the Consensus Committee. Pharmacopsychiatry. 22(1). 3–7. 34 indexed citations
12.
Ortíz, Julián M., et al.. (1986). Long-term randomized Clinical Trial on Oxcarbazepine vs Lithium in Bipolar and Schizoaffective Disorders: Preliminary Results.. Pharmacopsychiatry. 19(4). 282–283. 24 indexed citations
13.
Stoll, Klaus-Dieter, et al.. (1983). Test zur Erfassung der Schwere einer Depression. 5 indexed citations
14.
Heimann, H, et al.. (1977). Videotape training in psychiatric practice. Progress in Neuro-Psychopharmacology. 1(1-2). 141–145. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Hilde Lunde Breakdown of academic impact, for papers by Michael J. Napoliello Breakdown of academic impact, for papers by M Viukari Breakdown of academic impact, for papers by E. Lenzinger Breakdown of academic impact, for papers by S Malcolm Breakdown of academic impact, for papers by Josef Schöpf Breakdown of academic impact, for papers by Felix Veloso Breakdown of academic impact, for papers by Christian Geretsegger Breakdown of academic impact, for papers by M. Zivkov Breakdown of academic impact, for papers by Neil M. Kurtz
Rankless by CCL
2026